Your browser doesn't support javascript.
loading
Comorbidity identification and referral in atopic dermatitis: a consensus document.
Ortíz de Frutos, Javier; Carretero, Gregorio; de Lucas, Raul; Puig, Susana; Serra, Esther; Gómez Castro, Susana; Rebollo Laserna, Francisco; Loza, Estíbaliz; Silvestre-Salvador, Juan Francisco.
Afiliación
  • Ortíz de Frutos J; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Carretero G; Department of Dermatology, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain.
  • de Lucas R; Department of Dermatology, Hospital Universitario La Paz, Madrid, Spain.
  • Puig S; Department of Dermatology, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain.
  • Serra E; Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.
  • Gómez Castro S; Biomedical Research Networking Center on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain.
  • Rebollo Laserna F; Dermatology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Loza E; Pfizer Medical Department, Alcobendas, Madrid, Spain.
  • Silvestre-Salvador JF; Pfizer Medical Department, Alcobendas, Madrid, Spain.
J Dermatolog Treat ; 33(5): 2643-2653, 2022 Aug.
Article en En | MEDLINE | ID: mdl-35435103
ABSTRACT

BACKGROUND:

Atopic dermatitis (AD) is associated with different comorbidities.

OBJECTIVE:

To develop evidence-based and practical recommendations for comorbidity detection in patients with AD in daily practice.

METHODS:

We employed a modified RAND/UCLA methodology, including a systematic literature review (SLR). A group of six experts on AD was established. We conducted a comprehensive search strategy on Medline, Embase, and Cochrane Library up to June 2020. The selection criteria included studies with AD patients with any comorbidity reporting data on comorbidity prevalence, burden, and management. The included studies quality was assessed. The SLR results were discussed in a nominal group meeting, and several recommendations were generated. The recommendation agreement grade was tested on additional experts through a Delphi process.

RESULTS:

The recommendations cover the following issues (1) Which comorbidities should be investigated at the first and subsequent visits; (2) how and when should comorbidities be investigated (screening); (3) how should patients with specific comorbidities be referred to confirm their diagnosis and initiate management; (4) specific recommendations to ensure an integral care approach for AD patients with any comorbidity.

CONCLUSIONS:

These recommendations seek to guide dermatologists, patients, and other stakeholders in regard to early comorbidity identification and AD patient referral to improve decision-making.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Dermatitis Atópica Tipo de estudio: Diagnostic_studies / Guideline / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: J Dermatolog Treat Asunto de la revista: DERMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Dermatitis Atópica Tipo de estudio: Diagnostic_studies / Guideline / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: J Dermatolog Treat Asunto de la revista: DERMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: España